Literature DB >> 26416944

Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection--What Do We Know, and What More Do We Need to Know?

Charles Lee Bennett1, Terhi Hermanson2.   

Abstract

Entities:  

Keywords:  cardiovascular disease; chronic kidney disease; hemodialysis

Mesh：

Substances：

Year:  2015        PMID： 26416944      PMCID： PMC4594072          DOI： 10.2215/CJN.08060715

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  6 in total

1.  New therapies for diabetic kidney disease.

Authors:  Jonathan Himmelfarb; Katherine R Tuttle
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

2.  Developing the Sentinel System--a national resource for evidence development.

Authors:  Rachel E Behrman; Joshua S Benner; Jeffrey S Brown; Mark McClellan; Janet Woodcock; Richard Platt
Journal:  N Engl J Med       Date:  2011-01-12       Impact factor: 91.245

3.  Anaphylaxis and hypotension after administration of peginesatide.

Authors:  Charles L Bennett; Sony Jacob; Jeffrey Hymes; Len A Usvyat; Franklin W Maddux
Journal:  N Engl J Med       Date:  2014-05-22       Impact factor: 91.245

4.  US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Yi Li; Bruce Robinson; John Ayanian; Rajesh Balkrishnan; Jennifer Bragg-Gresham; Joline T L Chen; Elizabeth Cope; Debbie Gipson; Kevin He; William Herman; Michael Heung; Richard A Hirth; Steven S Jacobsen; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Alan B Leichtman; Yee Lu; Miklos Z Molnar; Hal Morgenstern; Brahmajee Nallamothu; Ann M O'Hare; Ronald Pisoni; Brett Plattner; Friedrich K Port; Panduranga Rao; Connie M Rhee; Douglas E Schaubel; David T Selewski; Vahakn Shahinian; John J Sim; Peter Song; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Paul W Eggers; Lawrence Y C Agodoa; Kevin C Abbott
Journal:  Am J Kidney Dis       Date:  2015-07       Impact factor: 8.860

5.  Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection.

Authors:  Julie H Ishida; Ben J Marafino; Charles E McCulloch; Lorien S Dalrymple; R Adams Dudley; Barbara A Grimes; Kirsten L Johansen
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-28       Impact factor: 8.237

6.  Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

Authors:  Tilman Drüeke; Véronique Witko-Sarsat; Ziad Massy; Béatrice Descamps-Latscha; Alain P Guerin; Sylvain J Marchais; Valérie Gausson; Gérard M London
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.